Demystifying Follicular Lymphoma:
Latest Advances in Precision Medicine and Emerging Therapies
Understand current and emerging options, including targeted therapies and bispecific antibodies, and how they address treatment challenges.
Take part in an engaging and informative webinar featuring Dr. Peter Martin, a leading lymphoma expert, to discuss the latest advancements in follicular lymphoma treatment. We will discuss precision medicine and emerging therapies, while addressing how to manage side effects and improve quality of life. This session is designed to empower patients with practical knowledge and support as they navigate their diagnosis.
Sign up for our program on December 26th at 12 pm PT / 3 pm ET and to be alerted to the replay.
- Get Expert Insights: Learn from Dr. Peter Martin, hematologist/oncologist and Chief of the Lymphoma Program at Weill Cornell Medicine
- Discover the Latest Treatments: Understand current and emerging options, including targeted therapies and bispecific antibodies, and how they address treatment challenges
- Empower Your Journey: Gain actionable strategies to manage side effects and improve quality of life
- Understand Personalized Care: Explore how precision medicine tailors treatment plans to individual needs, including chemo-free options
- Ask the Questions That Matter: Hear answers to common and critical questions about follicular lymphoma directly from an expert
- Get Advice from a Patient Advocate: Be part of a conversation that brings the patient experience front and center to inspire hope and informed decision-making
Program Speakers
Peter Martin, MD
Hematologist/Oncologist
Professor of Medicine and Chief of the Lymphoma Program
Weill Cornell Medicine
Laurie Adami
Follicular Lymphoma
Cancer Veteran, Cancer Legislative and Patient Advocate
Tiffany Drummon
Host, Cancer Advocate, and Clinical Researcher
The Patient Story
Thank you to The Leukemia & Lymphoma Society for their partnership. The Leukemia & Lymphoma Society is here for you with information about clinical trials, resources, and support.
Thank you to AbbVie and Genmab for their support of our patient education program! The Patient Story retains full editorial control over all content.
